Shares of Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report) rose 29.2% during mid-day trading on Thursday . The company traded as high as $21.75 and last traded at $21.70. Approximately 900 shares were traded during mid-day trading, a decline of 39% from the average daily volume of 1,483 shares. The stock had previously closed at $16.80.
Bone Biologics Price Performance
The firm has a fifty day moving average of $15.19 and a 200 day moving average of $13.71.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Stories
- Five stocks we like better than Bone Biologics
- Overbought Stocks Explained: Should You Trade Them?
- Why Amazon Could Be a $300 Stock Within Weeks
- Profitably Trade Stocks at 52-Week Highs
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
